Ron Do
Ron Do is a post-doctoral research fellow at the Center for Human Genetics Research, MGH and Broad Institute. He completed his M.Sc. in Epidemiology at the University of British Columbia and Ph.D in Human Genetics at McGill University. During his Ph.D., he studied the effects of genetic variants on lipids and cardiovascular disease using a variety of approaches including fine-mapping, gene-environment interaction and meta-analysis methods in gene association studies. He is currently investigating the role of low frequency variants and rare mutations in whole exome resequencing datasets of families with extreme lipid disorders and population-based samples with early onset myocardial infarction.
Chi Gao
Chi Gao is a research technician at the Center for Human Genetics Research, Massachusetts General Hospital (MGH). Chi received her B.A. in Biochemistry and Statistics with cum laude honor from Smith College. Her current research focuses on the molecular mechanisms underlying cardiovascular disease. She is also interested in identifying the role of genetic variants in plasma lipids and cardiovascular disease using statistical analysis tools.
Lindsey Hildebrand
Lindsey Hildebrand is the clinical research coordinator working on a study of the genetic basis for extreme HDL cholesterol levels. She completed her B.A. in psychology at Wellesley College along with pre-medical coursework. In the future, she hopes to pursue a career in medicine.
Vered Levy
Dr. Vered Levy is a research scientist at the Center for Human Genetic Research at Massachusetts General Hospital. She received her Ph.D. from The Hebrew University of Jerusalem, Israel in Cellular and Developmental Biology. She completed her postdoctoral fellowship at Harvard Medical School and Massachusetts General Hospital, where she studied epidermal stem cells. Following her postdoctoral training Dr. Levy managed Molecular Cytomics Inc. US Research and Development Section in collaboration with Boston University. Her research now focuses on the mechanisms involved in cardiovascular diseases.
Gina Peloso
Gina Peloso is a post-doctoral research fellow at the Center for Human Genetics Research, MGH. She completed her Ph.D in Biostatistics at Boston University. Her dissertation was on population structure in genetic association studies and the use of family data. While pursuing her Ph.D she was a research assistant working on statistical analysis with the Framingham Heart Study. She is currently working on targeted and exome sequencing projects with high/low lipid trait samples.
Vera Ruda
Dr. Vera Ruda is a Research Fellow affiliated with Massachusetts General Hospital (MGH) and the Broad Institute. Dr. Ruda received her M.Sc. in Virology from Moscow State University and her Ph.D. degree in Molecular Biology from the Institute of Bioorganic Chemistry in Moscow, Russia. She studied regulation of transcription in eukaryotes at Ecole Normale Superieure in Paris, France. Dr.Ruda is interested in the role non-coding sequences play in the genome.
Nate Stitziel
Nathan Stitziel is a postdoctoral fellow working on the genomics of early-onset myocardial infarction along with other cardiovascular traits. After obtaining his MD and PhD (Bioinformatics) from the University of Illinois, he completed an internship and residency in Internal Medicine at the University of Chicago. He is currently a clinical cardiology fellow at the Brigham and Women's Hospital.
Hayato Tada
Hayato Tada is a post-doctoral research fellow at the Center for Human Genetic Research, MGH. He is a clinical cardiologist (M.D.) and completed his Ph.D. from Kanazawa University in clinical lipidology. His focus of research is to detect the causative loci using whole exome sequencing for the families with extreme lipid profiles. And also he is going to get involved in the research for miRNA in terms of the relation with cardiovascular disease.
Yu-Xin Xu
Dr. Yuxin Xu is a research scientist at the Cardiovascular Research Center, Center for Human Genetic Research, affiliated with Massachusetts General Hospital (MGH). He received his bachelor of medicine from Anhui Medical University, China, and Ph.D. from Weizmann Institute of Science, Israel. He obtained his postdoctoral training in Columbia University, New York, where he studied the regulation of gene expression via transcription and pre-mRNA processing, as well as the mechanism of mitotic chromosome condensation in mammals. Following his postdoc he was employed as research assistant professor at the Department of Molecular and Cell Biology, Boston University Medical Campus, where he studied the metabolic regulation of mammalian glycosylation and the regulation of perlecan in the lipid binding and its implications in atherosclerosis. His current research is focusing on the molecular mechanism of the newly identified genetic factors in the lipoprotein metabolism and their significance in the cardiovascular diseases.